Tredje AP fonden cut its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 50.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 10,178 shares of the company's stock after selling 10,178 shares during the period. Tredje AP fonden's holdings in Henry Schein were worth $704,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also made changes to their positions in the company. Clarkston Capital Partners LLC raised its position in Henry Schein by 5.4% in the third quarter. Clarkston Capital Partners LLC now owns 1,397,805 shares of the company's stock valued at $101,900,000 after purchasing an additional 71,560 shares during the period. Nuance Investments LLC grew its stake in Henry Schein by 22.3% during the 3rd quarter. Nuance Investments LLC now owns 2,278,081 shares of the company's stock worth $166,072,000 after purchasing an additional 414,748 shares in the last quarter. Olstein Capital Management L.P. increased its stake in shares of Henry Schein by 17.2% during the fourth quarter. Olstein Capital Management L.P. now owns 109,000 shares of the company's stock worth $7,543,000 after buying an additional 16,000 shares during the period. B. Metzler seel. Sohn & Co. Holding AG acquired a new stake in shares of Henry Schein in the 3rd quarter valued at $515,000. Finally, Private Management Group Inc. boosted its position in shares of Henry Schein by 5.7% during the 4th quarter. Private Management Group Inc. now owns 350,515 shares of the company's stock worth $24,256,000 after acquiring an additional 18,882 shares in the last quarter. 96.62% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
HSIC has been the subject of several research analyst reports. UBS Group lowered their target price on shares of Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a report on Wednesday, February 26th. Barrington Research restated an "outperform" rating and set a $90.00 price target on shares of Henry Schein in a research note on Wednesday, February 26th. Jefferies Financial Group lifted their price target on Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a research report on Thursday, January 23rd. Bank of America raised Henry Schein from an "underperform" rating to a "buy" rating and increased their price objective for the company from $69.00 to $84.00 in a report on Monday, January 6th. Finally, Wells Fargo & Company began coverage on shares of Henry Schein in a research report on Friday, February 14th. They issued an "equal weight" rating and a $80.00 price target for the company. Six research analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $81.10.
Read Our Latest Stock Analysis on HSIC
Henry Schein Stock Performance
Shares of HSIC stock traded down $1.16 during mid-day trading on Wednesday, hitting $70.84. The stock had a trading volume of 2,352,243 shares, compared to its average volume of 1,507,564. The firm has a market cap of $8.80 billion, a PE ratio of 29.15, a PEG ratio of 2.13 and a beta of 0.90. The company's 50-day simple moving average is $74.85 and its 200-day simple moving average is $72.63. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. Henry Schein, Inc. has a fifty-two week low of $63.67 and a fifty-two week high of $82.49.
Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its quarterly earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing analysts' consensus estimates of $1.23 by ($0.04). Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business had revenue of $3.19 billion during the quarter, compared to analysts' expectations of $3.25 billion. During the same quarter last year, the firm earned $0.66 earnings per share. The firm's quarterly revenue was up 5.8% compared to the same quarter last year. Sell-side analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current year.
Henry Schein Profile
(
Free Report)
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Further Reading

Before you consider Henry Schein, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Henry Schein wasn't on the list.
While Henry Schein currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.